Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.405
+0.025 (0.57%)
Mar 3, 2026, 12:54 PM EST - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $248.73 million as of March 3, 2026. Its market cap has increased by 16.84% in one year.
Market Cap
248.73M
Enterprise Value
167.53M
1-Year Change
16.84%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $248.73M, an increase of 25.97%. That is a compound annual growth rate of 4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 247.32M | 5.54% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cibus | 254.01M |
| Shattuck Labs | 249.32M |
| OmniAb | 248.32M |
| Elicio Therapeutics | 248.15M |
| Coherus Oncology | 246.63M |
| Achieve Life Sciences | 244.34M |
| Sol-Gel Technologies | 241.75M |
| Surrozen | 236.74M |